RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Food and Drug Administration

A collection of news and information related to Food and Drug Administration published by this site and its partners.

Top Food and Drug Administration Articles

Displaying items 73-84
  • Howard County pets: What's the hype about raw diets?

    Howard County pets: What's the hype about raw diets?
    Q: I’ve heard a lot about raw dog food, but it seems pricey. Is it safe? Are the health benefits substantial? A: Raw diets for dogs (including raw meat) have become increasingly popular. Some pet owners -- even some veterinarians -- swear by them,...
  • In debate over 'biosimilars,' patient safety must come first

    In 1988, I became extremely ill. I had many tests, saw many doctors and was given various medicines. Some caused allergic reactions. Through it all, I remained sick — and actually became worse. Eventually, I was diagnosed with autoimmune hepatitis,...
  • Attorney general wants warning about affect of opiates on babies

    Attorney general wants warning about affect of opiates on babies
    Maryland Attorney General Douglas F. Gansler has joined 42 other attorneys general asking the FDA to put a warning label on opiod pain killers explaining the health consequences babies face when their mothers take the drugs while pregnant. The states'...
  • William H. Hoffman, engineer

    William H. Hoffman, engineer
    William H. Hoffman, a retired U.S. Food and Drug Administration official, died Monday from septic shock after kidney transplant surgery at the University of Maryland Medical Center. The longtime Ellicott City resident was 81. William Harry Hoffman was...
  • Budget cuts slow federal hiring in Md.

    Hiring for federal jobs in Maryland has fallen 30 percent since 2008, and for the first time in years is being outpaced by the number of employees retiring or resigning — a trend that has raised concerns among some about the government's ability...
  • Plan B restrictions — better, but not best

    Plan B restrictions — better, but not best
    In the United States of 2013, any youngster can walk into a store and buy a bottle of aspirin, acetaminophen, ibuprofen or some other pain reliever without showing any identification, parental consent or a doctor's order. They don't have to be 15 or 17 or...
  • Volunteers help veterans, and others, get their house in order

    The first troops showed up on a Saturday morning at the four-bedroom house in Columbia heavily armed: saws, hammers, crowbars, drills. They've returned three times since and are expected back again next week in hopes of making repairs upstairs and down,...
  • Scrabble at the Bain Center

    Activity Pals For single seniors. Get together with others to attend events, shop, go sightseeing, dine out and more. 301-596-6385. The Bain Center 5470 Ruth Keeton Way, Columbia. 410-313-7213. •Acting Up! Thursdays, 10:30 a.m. A theater...
  • Sacrifices lead to prime opportunity for G.G. Smith

    Sacrifices lead to prime opportunity for G.G. Smith
    Moving around has always been a big part of new Loyola basketball coach G.G. Smith's life. As a child whose father, Tubby, was a rising star in the college basketball coaching ranks, Smith spent time growing up in college towns like Columbia, S.C.,...
  • Sinai to research new drug to prevent blood clots, heart attacks in stent patients

    Sinai to research new drug to prevent blood clots, heart attacks in stent patients
    A Sinai Hospital cardiologist is launching a clinical trial of a type of coronary artery disease drug not yet tested in humans, building on a history at the Baltimore hospital of research to develop more effective treatments to prevent blood clotting....
  • Columbia firm is world's first to market with stem cell drug

    Columbia firm is world's first to market with stem cell drug
    A Columbia-based biotechnology company said this week it received the world’s first government approval to market a stem cell drug, in Canada. Osiris Therapeutics, founded in 1992, spent 17 years developing a stem cell therapy that offers anti-...
  • Md. to get $1.8 million in Abbott settlement over drug marketing

    Maryland is slated to receive $1.8 million for its part in a national settlement with Illinois-based Abbott Laboratories over allegations of illegal drug marketing, Attorney General Douglas F. Gansler said Monday. Abbott will pay $100 million to 44...